Anti-TGF-beta receptor II antibodies

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8147834
APP PUB NO 20100119516A1
SERIAL NO

12608034

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to antibodies against human transforming growth factor beta receptor II (TGFβRII), pharmaceutical compositions comprising antibodies and methods of using the antibodies, alone or in combination, for example, for treating cancer and fibrosis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
IMCLONE LLCC/O ELI LILLY AND COMPANY LILLY CORPORATE CENTER INDIANAPOLIS IN 46285

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Wu, Yan Flemington, US 454 4399

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation